The diagnostic value and clinical significance of a method for estimating the arterial stiffness BY cardio-ankle VASCULAR index


Cite item

Full Text

Abstract

The review presents the data of clinical studies of a new method for estimating the arterial stiffness by cardio-ankle vascular index (CAVI). The most significant factors influencing the vascular wall are analyzed and a CAVI measuring procedure and a calculation algorithm are described in detail. An association of the estimation of CAVI with other procedures determining the rigidity of the arterial wall is analyzed. A possibility for the practical application of this index to the study of the elastic properties of the vascular wall and for its use as a surrogate criterion to evaluate the vasoprotective effect of antihypertensive agents is considered.

References

  1. Погожева А. В. Диетологические аспекты первичной профилактики сердечно-сосудистых заболеваний у женщин с избыточной массой тела. Сердце 2004; 3(6): 295-298.
  2. Национальные клинические рекомендации Всероссийского науч. общества кардиологов. М.; 2007.
  3. Laurent S., Cockroft J., Van Bortel L. et al. Expert consensus document on arterial stiffness: methodological issuess and clinical applications. Eur. Heart J. 2006; 27: 2588-2606.
  4. Yambe T., Yoshizawa M., Sajio Y. et al. Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed. & Pharmacother. 2004; 58: S95-S98.
  5. Shirai K., Utino J., Otsuka K. et al. A novel blood pressure-independent arterial wall stiffness parameter: Cardio-Ankle Vascular Index (CAVI). J. Atheroscler. Thromb. 2006; 13(2): 101-107.
  6. Руководство по эксплуатации к прибору VaSera VS-1000 CAVI plus. Fukuda Denshi, с. 139.
  7. Милягина И. В., Милягин В. А., Поздняков Ю. М. и др. Сердечно-лодыжечный сосудистый индекс - новый предиктор сердечно-сосудистого риска. Кардиоваск. тер. и профилакт., 2008; 2(2): 22-26.
  8. Матросова И. Б. Артериальная ригидность при гипертонии I-II степени и возможности медикаментозной коррекции сосудистого ремоделирования у больных метаболическим синдромом: Автореф. дис. ... канд. мед. наук. М.; 2007. 14-16.
  9. Kubozono T., Miyata M., Ueyama K. et al. Clinical significance and reproducibility of new arterial distensibility index. Circ. J. 2007; 71: 89-94.
  10. Izuhara M., Shijoi K., Kadota S. et al. Relationship of cardio-ankle vascular index (CAVI) to carotid and coronary arteriosclerosis. Circ. J. 2008; 72: 1762-1767.
  11. Kumagai T., Kasai T., Kato M. et al. Establishment of the cardio-ankle vascular index in patients with obstructive sleep apnea. Chest 2009; 136(3): 779-786.
  12. Takenaka T., Hoshi H., Kato N. et al. Cardio-ankle vascular index to screen cardiovascular diseases in patients with end-stage renal diseases. J. Atheroscler. Thromb. 2008; 15: 339- 344.
  13. Nakamura K., Iizuka T., Takahashi M. et al. Association between cardio-ankle vascular index and serum cyctatin C levels in patients with cardiovascular risk factor. J. Atheroscler. Thromb. 2009; 16: 371-379.
  14. Ichihara A. Cardio-ankle vascular index and ankle pulse wave velocity as a marker of arterial fibrosis in kidney failure treated by hemodialysis. American Journal of Kidney Diseases doi: 10.1053/j.ajkd.2008.06.
  15. Hirai T., Sasayama S., Kawasaki T. et al. Stiffness of systemic arteries in patient with myocardial infarction: a non-invasive method to predict severity of coronary atherosclerosis. Circulation 1989; 80: 78-86.
  16. Tounian P., Aggoun Y., Dubern B. et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severity obese children: A prospective study. Lancet 2001; 358: 1400-1404.
  17. Nakamura K., Tomaru T., Yamamura S. et al. Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ. J. 2008; 72(4): 598-604.
  18. Takaki A., Ogawa H., Wakeyama T. et al. Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. Circ. J. 2007; 71(11): 1710-1714.
  19. Horinaka S., Yabe A., Yagi H. et al. Comparison atherosclerotic indicators between cardio-ankle vascular index, brachial-ankle pulse wave velocity. Angiology 2008; doi:10.1177/ 0003319708325443
  20. Okura T., Watanabe S., Kurata M. et al. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens. Res. 2007; 30(4): 335-340.
  21. Kadota K., Takamura N., Aoyagi K. et al. Availability of cardio-ankle vascular index (CAVI) as a screening tool for atherosclerosis. Circ. J. 2008; 72(2): 304-308.
  22. Izuhara M., Shioji K., Kadota S. et al. Relationship of cardio-ankle vascular index (CAVI) to carotid and coronary artheriosclerosis. Circ. J. 2008; 72(11): 1762-1767.
  23. Ibata J., Sasaki H., Kakimoto T. et al. Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure. Diabet. Res. Clin. Pract. 2008; 80(2): 265-270.
  24. Wakabayashi I., Masuda H. Relationships between vascular indexes and atherosclerotic risk factors in patients with type 2 diabetes mellitus. Angiology 2008; 59: 567.
  25. Ibata J., Sasaki H., Kakomoto T. et al. Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure. Diabet. Res. Clin. Pract. 2008; 80(2): 265-270.
  26. Mizuguchi Y., Oishi Y., Tanaka H. et al. Arterial stiffness is associated with left ventricular diastolic function in patients with cardiovascular risk factors: early detection with the use of cardio-ankle vascular index and ultrasonic strain imaging. J. Card. Fail. 2007; 13(9): 744-751.
  27. Takaki A., Ogawa H., Wakeyama T. et al. Cardio-ankle vascular index (CAVI) is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness. Hypertens. Res. 2008; 31: 1347-1355.
  28. Masugata H., Senda S., Himoto T. et al. Early detection of hypertension in a patient treated with sunitinib by measuring cardio-ankle vascular index. Tohoku J. Exp. Med., 2009; 218: 115-119.
  29. Sakane K., Miyoshi T., Doi M. et al. Association of new arterial stiffness parameter, the cardio-ankle vascular index, with left ventricular diastolic function. J. Atheroscler. Thromb. 2008; 15: 261-268.
  30. Huck C., Bronas U. et al. Noninvasive measurements of arterial stiffness: Repeatability and inter-relationships with endothelial function and arterial morphology measures. Vasc. Hlth Risk Manag. 2007; 3(3): 343-349.
  31. Otsuka K., Norboo T. et al. Chronoecological health watch of arterial stiffness and neuro-cardio-pulmonary function in elderly community at high altitude (3524 m), compared with Japanese town. Biomed. and Pharmacother. 2005; 59(Suppl. 1): S58-S67.
  32. Huang C. L., Chen M. F., Jeng J. S. et al. Postchallenge hyperglycaemic spike associate with arterial stiffness. Int. J. Clin. Pract. 2007; 61(3): 397-402.
  33. Wakabayashi I., Masuda H. Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus. Clin. Chim. Acta 2006; 365(1-2): 230-235.
  34. Ueyama K., Miyata M., Kubozono T. et al. Noninvasive indices of arterial stiffness in hemodialysis patients. Hypertens Res. 2009. Jun 12 doi: 10.1038/hr.2009.83
  35. Кобалава Ж. Д., Котовская Ю. В. и др. Высокое систолическое давление - акцент на эластические свойства артерий. Кардиоваск. тер. и профилакт. 2006; 6: 10-16.
  36. Masugata H., Senda S., Goda F. et al. Tissue Doppler echocardiography for oredicting arterial stiffness assessed by cardio-ankle vascular index. Tohoku J. Exp. Med. 2009; 217: 139-146.
  37. Satoh N., Shimatsu A., Kato Y. et al. Evaluation of the cardio-ankle vascular index a new indicator of arterial stiffness independent of blood pressure in obesity and metabolic syndrome. Hypertens. Res. 2008; 31: 1921-1930.
  38. Yamamoto N., Yamanaka G., Ishikawa M. et al. Cardio-ankle vascular index as a predictor of cognitive impairment in community-dwelling elderly people: four-year follow-up. Dement. Geriatr. Cogn. Disord. 2009; 28: 153-158.
  39. Lee J. A., Kim D. H., Yu S.-J. et al. Association of serum albumin and homocysteine levels and cardio-ankle vascular index in patients with continuous ambulatory peritoneal dialysis. Korean. J. Intern. Med. 2006; 21(1): 33-38.
  40. Матросова И. Б., Елисеева И. В., Борисова Н. А. и др. Механизмы сосудистого ремоделирования при гипертонии и метаболическом синдроме. Изв. высш. учеб. заведений. Поволж. регион. Мед. науки 2008; 1: 45-54.
  41. Лукьянов М. М., Бойцов С. А. Артериальная ригидность у больных артериальной гипертонией. Современное состояние вопроса и перспективы продвижения от научных исследований к практике. Сердце 2008; 7(6): 34-36.
  42. Агеев Ф. Т., Орлова Я. А., Нуралиев Э. Ю. и др. Скорость пульсовой волны - предиктор развития сердечно-сосудистых осложнений у мужчин с ишемической болезнью сердца. Кардиол. вестн. 2007; 2(1): 178-183.
  43. Yambe T., Meng X., Hou X. et al. Cardio-ankle vascular index (CAVI) for the monitoring of the atherosclerosis after heart transplantation. Biomed. & Pharmacother. 2005; 59: S177- S179.
  44. Sato H., Miida T., Wada Y. et al. Atherosclerosis is accelerated in patients with long-term well-controlled Systemic Lupus Erythematosus (SLE). Clin. Chim. Acta 2007; 385(1-2): 35- 42.
  45. Олейников В. Э., Герасимова А. С., Матросова И. Б., Томашевская Ю. А. Эффективность и органопротективное действие спираприла у больных метаболическим синдромом и артериальной гипертензией. Рос. кардиол. журн. 2007; 4: 34-43.
  46. Ohashi N., Ito C., Fujikawa R. et al. The impact of visceral adipose tissue and high-molecular weight adiponectin on cardio-ankle vascular index in asymptomatic Japanese subjects. Metabolism 2009; 58(7): 1023-1029.
  47. Albert H. VAT more predictive of cardio-ankle vascular index than adiponectin. Metabolism 2009; 58: 1035-1040.
  48. Masugata H., Senda S., Himoto T. et al. Detection of increased arterial stiffness in a patient with early stage of large vessel vasculitis by measuring cardio-ankle vascular index. Tohoku J. Exp. Med. 2009; 219: 101-105.
  49. Поздняков Ю. М., Волков С. В., Милягин В. А., Якушин С. С. Монотерапия артериальной гипертензии I-II степени. Опыт применения лизиноприла (результаты многоцентрового исследования). Бол. сердца и сосудов 2006; 1(4).
  50. Голованова Е. Д. Ремоделирование сосудов и вариабельность сердечного ритма при фармакотерапии артериальной гипертензии различными средствами. Рацион. фармакотер. в кардиол. 2006; 1: 62-66.
  51. Кобалава Ж. Д., Котовская Ю. В., Маркова М. А., Виллевальде С. В. Высокое систолическое давление: акцент на эластические свойства артерий. Кардиоваск. тер. и профилакт. 2006; 6: 10-16.
  52. Kurata M., Okura T., Watanabe S. et al. Effects of amlodipine and candesartan on arterial stiffness estimated by cardio-ankle vascular index in patients with essential hypertension: A 24-week study. Curr. Ther. Res. 2008; 69(5): 412-422.
  53. Miyashita Y., Saiki A., Endo K. et al. Effects of olmesartan, an angiotensin II receptor blocker and amlodipine, A calcium channel blocker, on cardio-ankle vascular index (CAVI) in type 2 diabetic patients with hypertension. J. Atheroscler. Thromb. 2009; 16: 621-626.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies